Evidence map›Paper›PMID 33065557›Full record

ArticleJournal of breath research2020

Exhaled breath condensate biomarkers in critically ill, mechanically ventilated patients.

Michael D Davis, Brett R Winters, Michael C Madden, Joachim D Pleil, Curtis N Sessler, M Ariel Geer Wallace, Cavin K Ward-Caviness, Alison J Montpetit

Open access · greenAbstract read
In one paragraph

Article in Journal of breath research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Harnessing breath biomarkers for pneumonia diagnosis and prognosis.Expert review of respiratory medicine · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Michael D DavisWells Center for Pediatric Research/Pulmonology, Allergy, and Sleep Medicine, Riley Hospital for Children at Indiana University, 1044 W. Walnut Street R4-472, Indianapolis, IN 46202, United States of America.ORCID 0000-0001-9387-1961
Brett R WintersGSI Environmental Inc., Oakland, CA, United States of America.
Michael C MaddenPublic Health and Integrated Toxicology Division Center for Public Health and Environmental Assessment U.S. Environmental Protection Agency Research Triangle Park, NC, United States of America.
Joachim D PleilDepartment of Environmental Sciences and Engineering Gillings School of Public Health, University of North Carolina, Chapel Hill, NC, United States of America.ORCID 0000-0001-8211-0796
Curtis N SesslerDepartment of Internal Medicine, Division of Pulmonary Disease and Critical Care, Medicine Virginia Commonwealth University School of Medicine, Richmond, VA, United States of America.
M Ariel Geer WallaceAir Methods and Characterization Division Center for Environmental Measurement and Modeling U.S. Environmental Protection Agency Research Triangle Park, NC, United States of America.
Cavin K Ward-CavinessPublic Health and Integrated Toxicology Division Center for Public Health and Environmental Assessment U.S. Environmental Protection Agency Research Triangle Park, NC, United States of America.
Alison J MontpetitNursing Research and Innovation, Patient Care Services VCU Health System, Richmond, VA, United States of America.
Environmental Protection Agency · USGSI Environmental (United States) · USOffice of Patient Care Services · USRiley Hospital for Children · USUniversity of North Carolina at Chapel Hill · USVirginia Commonwealth University · US

Funding

Research Supplement to Promote Diversity in Health Related ResearchUL1TR002649 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2018 to 2022
$19.1M
Project 3 - Personalized cystic fibrosis treatment strategies with synergistic therapies Identified in vitro.P01HL128192 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN · 2016 to 2020
$12.2M
Exhaled Biomarkers of Pulmonary Infection in the Critically IllR00NR012016 · NINR · VIRGINIA COMMONWEALTH UNIVERSITY · PI MONTPETIT, ALISON JONES · 2012 to 2014
$727k
Intramural EPA EPA999999NCATS NIH HHS UL1 TR002649NHLBI NIH HHS P01 HL128192NINR NIH HHS R00 NR012016
6 · The paper itself

Abstract

Pneumonia is a significant risk for critically ill, mechanically ventilated (CIMV) patients. Diagnosis of pneumonia generally requires a combination of clinician-guided diagnoses and clinical scoring systems. Exhaled breath condensate (EBC) can be safely collected non-invasively from CIMV patients. Hundreds of biomarkers in EBC are associated with acute disease states, including pneumonia. We evaluated cytokines in EBC from CIMV patients and hypothesized that these biomarkers would correlate with disease severity in pneumonia, sepsis, and death. EBC IL-2 levels were associated with chest radiograph severity scores (odds ratio = 1.68; 95% confidence interval = 1.09-2.60; P = 0.02). EBC TNF-α levels were also associated with pneumonia (odds ratio = 3.20; 95% confidence interval = 1.19-8.65; P = 0.02). The techniques and results from this study may be useful for all mechanically ventilated patients.

Indexed as

Critical IllnessExhalationRespiration, ArtificialAcute DiseaseAdultBiomarkersBreath TestsHumansInterleukin-1betaLinear ModelsMaleMiddle AgedPneumoniaSepsisThoraxTreatment OutcomeBiomarkersInterleukin-1betaTumor Necrosis Factor-alpha

Identifiers

PMID33065557
PMCPMC9003134
OpenAlexW3092902390

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.